Home » Topics » Regulatory

Regulatory
RSS

Glaxo Wellcome claims GR-79236 for reducing myocardial injury

July 26, 1996

Bifemelane claimed for cerebrovascular disorders treatment

July 26, 1996

CP-122638: Pfizer's potential treatment for non-migraine emesis

July 26, 1996

5-HT3/NK1 antagonist combination effective in emesis treatment and prevention

July 26, 1996

Chinoin describes new selegiline formulation

July 26, 1996

Raloxifene indicated for excess NPY associated disorders

July 26, 1996

Duloxetine claimed for new indication

July 26, 1996

Fujisawa claims tacrolimus as allergic conjunctivitus treatment

July 26, 1996

Ciclosporin demonstrates efficacy and safety as an antimetabolite

July 26, 1996

InSite Vision and Bausch & Lomb announce alliance regarding glaucoma drug

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.